| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000037947 |
| Receipt No. | R000043255 |
| Scientific Title | Verification of clinical effect of 3D printing dentures by randomized controlled trial |
| Date of disclosure of the study information | 2020/01/01 |
| Last modified on | 2019/09/07 (Ver. 3) |
| Basic information | ||
| Public title | Verification of clinical effect of 3D printing dentures by randomized controlled trial | |
| Acronym | Verification of clinical effect of 3D printing dentures | |
| Scientific Title | Verification of clinical effect of 3D printing dentures by randomized controlled trial | |
| Scientific Title:Acronym | Verification of clinical effect of 3D printing dentures by randomized controlled trial | |
| Region |
|
|
| Condition | ||
| Condition | Edentulous jaw | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Dental computer-aided designs and computer-aided machining (CAD/CAM) technology has rapidly improved from the beginning of the 21st century with the remarkable development of digital technology . in the field of dental prosthesis, prosthetic devices are manufactured by CAD/CAM.Especially in the CAD / CAM crown, it has spread rapidly due to the inclusion of social insurance and the acquisition of optical impressions. On the other hand, CAD / CAM has also been attempted for complete dentures. Development of high-strength PMMA discs and resin for 3D printers is also progressing rapidly , and the spread of CAD / CAM complete dentures is expected.However, there are few reports of clinical application cases of complete dentures made using a 3D printer, and there are many unclear points.Therefore, in establishing clinical evidence, comprehensive evaluation will be performed based on subjective and objective evaluation of complete dentures manufactured using a 3D printer. It is considered very useful to accumulate and report evidence that contributes to the formulation of clinical guidelines for complete dentures made using 3D printers. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | Oral Health-related QOL Scale OHIP-EDENT-J |
| Key secondary outcomes | Patient satisfaction (100mmVAS)
Direct and indirect expenses and time required for medical care Three-dimensional data of denture shape Chewing efficiency Occlusal contact area Success rate Complications |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | The control group manufactures complete dentures according to the law. | |
| Interventions/Control_2 | In the intervention group, the occlusal plate obtained by occlusion and the mucosal surface of the work model are scanned with a model scanner. The denture is designed based on the STL data. After that, the denture is made with a 3D printer. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Adults with upper and lower edentulous jaws2) Those who have old dentures and who want to make complete dentures3) Those who can visit the hospital regularly and agree to the research4) Those who have received sufficient explanation for participation in this study, and who have received sufficient written consent from the patient himself / herself with sufficient understanding | |||
| Key exclusion criteria | 1) Person with temporomandibular disorder2) Person with jaw defect3) Those who have problems with their general health and may have difficulty in dental treatment.4) Those who have difficulty in communicating for treatment due to dementia, etc.5) Those who have significant difficulty in going to hospital due to physical, mental or social reasons6) In addition, the person in charge of the research or the person judged by the researcher to be inappropriate for conducting this research safely | |||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tsurumi University School of Dental Medicine | ||||||
| Division name | Removable Prosthodontics | ||||||
| Zip code | 230-8501 | ||||||
| Address | 2-1-3,Tsurumi,Tsurumi-ku, Yokohama 230-8501 | ||||||
| TEL | 0455808414 | ||||||
| okubo-c@tsurumi-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tsurumi University School of Dental Medicine | ||||||
| Division name | Removable Prosthodontics | ||||||
| Zip code | 230-8501 | ||||||
| Address | 2-1-3,Tsurumi,Tsurumi-ku, Yokohama 230-850 | ||||||
| TEL | 0455808414 | ||||||
| Homepage URL | |||||||
| shimpo-hidemasa@tsurumi-u.ac.jp | |||||||
| Sponsor | |
| Institute | surumi University School of Dental Medicine Removable Prosthodontics |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Mitsui Chemicals, Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Tokyo medical and dental university |
| Address | 1-5-45, Yushima, Bunnkyoku,Tokyo |
| Tel | 0358034712 |
| d-hyoka.adm@tmd.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043255 |